Lab Information

Ciriaco Piccirillo (PhD)

Senior Scientist
Centre for Translational Biology
Department of Microbiology & Immunology (McGill)

Research Profile

 Fundamental: 100%
 Clinical: 0%
 Epidemiology: 0%
 Evaluation: 0%
 This email address is being protected from spambots. You need JavaScript enabled to view it.
 http://www.piccirillolab.wix.com/piccirillolab

Keywords

Immunology • T cell biology • autoimmune diseases • inflammatory diseases

Research Interests

My research focuses on the regulation of innate and adaptive immune responses mediated by Foxp3+ regulatory T (Treg) cells, a unique population of CD4+ T cells with potent immunosuppressive functions in humans and mice. Normal development and function of Foxp3+ Treg cells is essential for the protection from autoimmune diseases and developmental or functional defects in Treg cells in mice and humans unequivocally provokes many inflammatory and autoimmune diseases. Our research is responsible for many seminal studies over the past decade related to the function and mechanism of action of Treg cells in a variety of animal models, non-human primates and humans. My research program aims to determine whether Treg cell developmental, functional or homeostatic deficiencies trigger various inflammatory disorders, and in particular autoimmune diseases like type 1 diabetes (T1D). My laboratory exploits a spectrum of molecular and cellular approaches to study the development, dynamics and molecular basis of Treg cell function in health and disease.


Team Members

Name Position

Latest Publications

  1. Alvarez, F., Acuff, N. V., La Muraglia, G. M., Sabri, N., Milla, M. E., Mooney, J. M., Mackey, M. F., Peakman, M. & Piccirillo, C. A. (2024). The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes. JCI insight, vol. 9.
  2. Hes, C., Gui, L., Bay, A., Alvarez, F., Katz, P., Paul, T., Bozadjieva-Kramer, N., Seeley, R. J., Piccirillo, C. A. & Sabatini, P. (2024). GDNF family receptor alpha-like (GFRAL) expression is restricted to the caudal brainstem. Molecular metabolism, p. 102070.
  3. Al-Aubodah, T.-A., Piccirillo, C. A., Trachtman, H. & Takano, T. (2024). The autoimmune architecture of childhood idiopathic nephrotic syndrome. Kidney international.
  4. Cuperlovic-Culf, M., Bennett, S. A. L., Galipeau, Y., McCluskie, P. S., Arnold, C., Bagheri, S., Cooper, C. L., Langlois, M.-A., Fritz, J. H., Piccirillo, C. A. & Crawley, A. M. (2024). Multivariate analyses and machine learning link sex and age with antibody responses to SARS-CoV-2 and vaccination. iScience, vol. 27, p. 110484.
  5. da Silva Lira Filho, A., Lafleur, A., Alvarez, F., Piccirillo, C. A. & Olivier, M. (2024). Implication of the Annexin 1/FPR axis in leishmanial exosome-mediated Leishmania major skin hyperpathogenesis. Frontiers in immunology, vol. 15, p. 1436151.
  6. Huang, J., Michaud, E., Shinde-Jadhav, S., Fehric, S., Marcq, G., Mansure, J. J., Cury, F., Brimo, F., Piccirillo, C. A. & Kassouf, W. (2024). Effects of combined radiotherapy with immune checkpoint blockade on immunological memory in luminal-like subtype murine bladder cancer model. Cancer biology & therapy, vol. 25, p. 2365452.
  7. Lachance, G., Robitaille, K., Laaraj, J., Gevariya, N., Varin, T. V., Feldiorean, A., Gaignier, F., Julien, I. B., Xu, H. W., Hallal, T., Pelletier, J.-F., Bouslama, S., Boufaied, N., Derome, N., Bergeron, A., Ellis, L., Piccirillo, C. A., Raymond, F., Fradet, Y., Labbé, D. P., Marette, A., Fradet, V., Lachance, G., Robitaille, K., Laaraj, J., Gevariya, N., Varin, T. V., Feldiorean, A., Gaignier, F., Julien, I. B., Xu, H. W., Hallal, T., Pelletier, J.-F., Bouslama, S., Boufaied, N., Derome, N., Bergeron, A., Ellis, L., Piccirillo, C. A., Raymond, F., Fradet, Y., Labbé, D. P., Marette, A. & Fradet, V. (2024). The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids. Nature communications, vol. 15, p. 3431.
  8. Alvarez, F., Liu, Z., Bay, A. & Piccirillo, C. A. (2024). Deciphering the developmental trajectory of tissue-resident Foxp3+ regulatory T cells. Frontiers in immunology, vol. 15, p. 1331846.
  9. Almeida, N. D., Schiller, I., Ke, D., Sakr, E., Plesa, M., Vanamala, S., Moneger, A.-L., Bazan, M., Lucchesi, C., Wozniak, N., Fritz, J. H., Piccirillo, C. A., Pelchat, M., Arnold, C., Galipeau, Y., McCluskie, P. S., Langlois, M.-A., Dasgupta, K. & Mazer, B. D. (2024). The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study. Frontiers in immunology, vol. 15, p. 1330549.
  10. Attias, M. & Piccirillo, C. A. (2024). The impact of Foxp3+ regulatory T-cells on CD8+ T-cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors. British journal of pharmacology.
More on PubMed 



See also

Card image
Martin
Olivier


See profile
Card image
Moshe
Ben-Shoshan


See profile
Card image
Carolyn
Jack


See profile
Card image
Brian
Ward


See profile
Card image
Michael
Reed


See profile